Brief: Medicover Announces Positive Interim Results From Dart Study
02/06/2025 07:33
June 2 (Reuters) - Medicover AB MCOVb.ST: ANNOUNCES POSITIVE INTERIM RESULTS FROM DART STUDY INITIAL RESULTS FROM DART STUDY INDICATE THAT MEDICOVER GENETICS' MRD TEST CAN DETECT MINIMAL RESIDUAL DISEASE IN LUNG CANCER PATIENTS Source text: ID:nMFN8cRHSh Further company coverage: [MCOVb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Medicover AB
See all newsSweden's Medicover Q3 profit rises 29% on price adjustments and wider network; to focus on Europe
Brief: Medicover Reports Q3 EBIT Of €49.3 Million
Medicover India hospitals to be profitable in 18 months, eyes 20-25% margins (updated)
Medicover India's 25 hospitals to be profitable in 18 months, executive says
Brief: Medicover Board Member Acquires Shares Worth SEK 23 Mln In Company